Stock Rating Report for PFE

Ticker: 

Stock Information

Ticker PFE
Company Name Pfizer Inc
Current Price $21.20
Previous Close $21.20
Industry Drug Manufacturers - Major
Sector HEALTHCARE
Long Stop Loss Members Only
Short Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

StockProphet Ratings

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

Sector Risks

Sign up for MarketProphet today to see our 30, 60, and 90 day risk assessment for this stock.


Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for PFE. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Pfizer Inc next week. Sign up today and start making money!

Demand Fundamentals

Demand Fundamental Value Score Rating
Qtr/Qtr Revenue Growth Members Only
Qtr/Qtr Earnings Growth Members Only
Year/Year Revenue Growth Members Only
Year/Year Earnings Growth Members Only
Multi-Year Revenue Growth Members Only
Multi-Year Earnings Growth Members Only
Relative PE Ranking Members Only
Return on Equity Members Only
Yield Members Only
Institutional Holding Members Only
Stock Price Members Only
Relative Fundamental Ranking Members Only
Total Score Members Only

Demand Technicals

Demand Technical Value Score Rating
Recommended Condition Members Only
Trading Zone Members Only
Average Trading Volume Members Only
Industry Bull/Bear Condition Members Only
Sector Bull/Bear Condition Members Only
Current Signal Start Date Members Only
Total Score Members Only

Company Profile

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood- Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis- Lyrica for post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, neuropathic pain, adjunctive treatment of epilepsy, and general anxiety disorder, as well as for use as an adjunctive therapy for adult patients with partial onset seizures- Prevnar/Prevenar for invasive pneumococcal disease- Celebrex for osteoarthritis and rheumatoid arthritis, and acute pain- Viagra for erectile dysfunction- Xalabrands for reducing elevated eye pressure- Effexor XR for depressive, generalized anxiety, social anxiety, and panic disorders- and Norvasc for hypertension. It also offers Zyvox for gram-positive pathogens- Premarin for menopausal symptoms- Sutent for renal cell carcinoma- Geodon/Zeldox for schizophrenia- Detrol/Detrol LA for overactive bladder- Zosyn/Tazocin, an intravenous antibiotic- Genotropin for growth hormone deficiency- Vfend, an antifungal agent- and Protonix for gastroesophageal reflux disease- Chantix/Champix for aid smoking cessation- BeneFIX, ReFacto AF, and Xyntha for lifelong bleeding disorder- Caduet for cardiovascular events- Revatio for pulmonary arterial hypertension- Pristiq for depressive disorder- Aricept for Alzheimer's disease- and Spiriva for breathing problems. The company's Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides- consumer healthcare products, such as dietary supplements, pain management, respiratory, and personal care- nutrition products- and gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.


Latest News

Sat, 04 Feb 2012 18:04:25 GMTThe 3 Worst Dow Stocks This Week
Sat, 04 Feb 2012 14:00:00 GMTMerck's Lower Tax Rate
Sat, 04 Feb 2012 11:08:03 GMT3 Stocks on Our Radar
Fri, 03 Feb 2012 23:36:00 GMTKeller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/OvralŽ-28 and Norgestrel Birth Control Pill Recall
Fri, 03 Feb 2012 23:04:06 GMTMost active New York Stock Exchange-traded stocks
Fri, 03 Feb 2012 23:03:45 GMTFinal Glance: Pharmaceuticals companies
Fri, 03 Feb 2012 21:38:29 GMTCuring Diseases Makes For a Bad Business Model
Fri, 03 Feb 2012 21:26:32 GMTAstraZeneca - Solid Earnings Overwhelmed By An Uncertain Future
Fri, 03 Feb 2012 21:16:21 GMTU.S. Companies Issuing Profit Outlooks for the Week of Feb. 3
Fri, 03 Feb 2012 20:49:56 GMTStocks jump on strong jobs report for January
Fri, 03 Feb 2012 19:53:58 GMTMerck Looks Like A Name To Own In Drugs
Fri, 03 Feb 2012 19:08:20 GMTIndexes Hold Firm While Tech Shares Advance
Fri, 03 Feb 2012 19:06:12 GMTGilead's Hep C Results Send Shares Sharply Higher
Fri, 03 Feb 2012 18:41:15 GMTMidday Glance: Pharmaceuticals companies
Fri, 03 Feb 2012 18:28:10 GMTThe Cash Kings Of The Dow
Fri, 03 Feb 2012 18:09:18 GMTBioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
Fri, 03 Feb 2012 17:47:12 GMTThis Just In: Upgrades and Downgrades
Fri, 03 Feb 2012 16:15:00 GMTThe "Buffett Rule" is propaganda (Updated)
Fri, 03 Feb 2012 15:29:13 GMTEarly Glance: Pharmaceuticals companies
Fri, 03 Feb 2012 15:07:20 GMTHas Elan Become the Perfect Stock?
News provided by Yahoo! Finance